logo
Supranext Launches Complementary Currencies in the US to Strengthen Local Economies and Support Small Businesses

Supranext Launches Complementary Currencies in the US to Strengthen Local Economies and Support Small Businesses

06/12/2025, Rome, Italy // PRODIGY: Feature Story //
Supranext, a next-generation hybrid financial operator, announces the launch of its three-tiered complementary currency system, comprising a crypto-based token, physical paper vouchers, and metallic coins. The system aims to function alongside national currencies, offering a new form of liquidity to underserved regions and businesses.
Supranext
'Our goal is to infuse vitality into the parts of the US economy that have been left behind,' says David Baccini, CEO of Supranext. 'Our complementary currencies exist to help revive what has stopped working. We want to empower businesses and communities with monetary mechanisms that reflect their real needs and not the constraints of global finance.'
Supranext's complementary currencies are organized across three geographic layers: global, macro-zonal, and regional. These currencies, namely Supra, Solidus, and Denarius, respectively, are designed to function within predefined areas of economic activity.
The Supra represents the global tier and operates similarly to the theoretical bancor currency envisioned by economist John Maynard Keynes. Below it, the Solidus corresponds to macro zones, such as the US as a whole. Meanwhile, Denarius targets specific regions or states, like Texas or New York.
Each of these currencies exists in three forms: a digital token, paper vouchers, and metallic coins. Their issuance is uncapped in quantity but strictly regulated in value fluctuation, using what Supranext's Veronika Nova, a member on the board of directors, calls a Narrowed Band of Oscillation Tokens (N-BOOT). This ensures that Supranext's tokens would shift away from the volatile investment vehicles.
'They're intended to circulate rapidly within local economies, with a projected velocity of five times that of traditional fiat currencies,' Baccini explains. This controlled, high-velocity model is meant to stimulate real economic transactions rather than speculative hoarding.
To support liquidity and maintain value stability, Supranext introduces a novel mechanism it calls 'revolving doors.' When users accept or use complementary currencies, they do so with the assurance that a portion of the system's global bond reserves will periodically be used to buy back tokens on Supranext's platform.
If the token value surges, additional currency is issued to prevent bubbles. On the other hand, if value declines, short-term notes denominated in reserve currencies will be issued to absorb the excess supply. This floor-and-ceiling system keeps the tokens within a tight value band. It allows users to treat them as stable, usable instruments of exchange.
On top of this, Supranext will be providing RePo through their complementary currencies, proving true liquidity for those who need it. Whether it be patents, works of art, life settlements, tax credits, quotas of invest funds, shares of non-public companies, and much more, people will now have more options at their disposal.
David Baccini
The launch of these complementary currencies serves as a response to visible fractures in global monetary systems. Over 60 percent of small US businesses reported difficulty accessing affordable credit. According to the US Small Business Administration, small businesses account for 44 percent of economic activity. Yet, their access to growth capital has declined steadily.
Supranext also addresses the issue regarding what economists refer to as the 'Cantillon Effect,' where newly created money disproportionately benefits those closest to its source while bypassing the majority of businesses and households. 'This means that liquidity generated by central banks accumulates at the top. What happens then? Local economies are left dry,' Baccini states. 'Our complementary currencies intend to inject liquidity precisely into the hands of small businesses and consumers, particularly in economically stagnant regions.'
This is possible because Supranext is a product of over a decade of research and development. Supranext is known for its proprietary financial system built around an algorithm capable of issuing bonds with high resilience and low correlation to traditional markets. These bonds are designed to achieve investment-grade ratings while being directed toward high-risk or underserved sectors. 'This is how we offer capital to businesses that would otherwise be left out of the global financial ecosystem,' Baccini states.
The complementary currencies are designed to function hand-in-hand with these bonds. For example, a small manufacturing firm in upstate New York may receive capital through Supranext bonds while also transacting daily using Denarius tokens. Should they wish to convert Denarius to dollars, Supranext's revolving mechanism and buyback protocols allow for an orderly return to fiat currency, bridging the alternative and traditional economies.
By combining alternative currency, bond-backed investment, and integrated economic networks, Supranext introduces a new kind of financial architecture. It's proud to share that its ambitions are global. With operations beginning in New York and an initial expansion in Italy, the company plans to scale across key economic zones worldwide.
There is no offer to sell, no solicitation of an offer to buy, and no recommendation of any security or any other product or service in this article. Moreover, nothing contained in this should be construed as a recommendation to buy, sell, or hold any investment or security, or to engage in any investment strategy or transaction. It is your responsibility to determine whether any investment, investment strategy, security, or related transaction is appropriate for you based on your investment objectives, financial circumstances, and risk tolerance. Consult your business advisor, attorney, or tax advisor regarding your specific business, legal, or tax situation.
Media Contact
Name: Supranext Team
Email: [email protected]

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Liverpool 'drops' $80M Darwin Nunez asking price as Napoli wants transfer
Liverpool 'drops' $80M Darwin Nunez asking price as Napoli wants transfer

Yahoo

time2 hours ago

  • Yahoo

Liverpool 'drops' $80M Darwin Nunez asking price as Napoli wants transfer

Liverpool has reportedly dropped its asking price for Darwin Nunez, and would accept a fee of around €50 million ($58 million) plus add-ons for the Uruguayan striker. Nunez is widely expected to leave Liverpool this summer, three years on from a big-money transfer from Benfica. Liverpool knocked back approaches for Nunez from clubs in Saudi Arabia during the January transfer window, but there remains a strong market for the Reds' No. 9 during the ongoing summer window. Advertisement The interest from Saudi Arabia remains, while Atletico Madrid, Napoli and AC Milan are also being linked with the 25-year-old. It's claimed that Napoli has made a verbal offer of around €43 million ($50 million) for Nunez, with Napoli said to be keen to provide support to Romelu Lukaku in its front line. READ MORE: Milos Kerkez can give Arne Slot what wanted as Liverpool transfers prove Virgil van Dijk right READ MORE: Liverpool transfer news LIVE: Florian Wirtz medical, Alexander Isak deal, Marc Guehi interest Foot Italia reports that Nunez has no intention of moving to Saudi Arabia, as he wants to remain playing at a high level in Europe. Advertisement Napoli boss Antonio Conte is said to be a fan of Nunez and believes he has a higher chance of realizing his potential away from the Premier League. Transfer guru Fabrizio Romano gave an update on Napoli's interest in Nunez earlier this week, saying that concrete talks have been taking place ahead of a possible move. "We are keeping the names that have been mentioned in recent days regarding Napoli's attack," Romano said, as quoted by Tutto Napoli. "I told you about Darwin Nunez, who has moved from phone calls to serious, direct and concrete contacts. "Napoli is working on the Darwin Nunez operation, but it is not an easy operation. There is competition from other clubs, including some from Saudi Arabia. We will understand more in the next few days, but it is a move that the Azzurri certainly want to try to make. Advertisement "There have also been calls from AC Milan to be informed about the situation, but the Italian club that is working hard on the Uruguayan striker - also with the player's agents - is Napoli. "Now we will have to understand if it will be feasible from an economic and competition point of view, but the certainty is that Darwin Nunez will leave Liverpool." Nunez is leaving Liverpool -Credit:Getty Images Meanwhile, former Liverpool midfielder Dietmar Hamann wants to see Liverpool chance its arm with an audacious swap offer involving Nunez and Atletico Madrid striker Julian Alvarez. "I'd love to see Julian Alvarez at Liverpool and I think Darwin Nunez being part of the deal would make a lot of sense," Hamann told "I think Nunez is tailor-made for Atletico Madrid as a physical centre forward, someone who will work so hard, which is what Diego Simeone wants. Advertisement "Alvarez would also be a fantastic addition at Liverpool. He played in the shadow of Erling Haaland at Manchester City, but really added to his reputation in Madrid. "He led the line, scored goals, and made life a nuisance for the back lines he played against. I think he would be a brilliant signing. "There are rumors about other forwards, but Alvarez would be a great addition to Liverpool, and Nunez might just be an even better signing for Atletico."

SINOVAC Board of Directors Prevails Against Advantech/Prime's New York Lawsuit
SINOVAC Board of Directors Prevails Against Advantech/Prime's New York Lawsuit

Business Wire

time3 hours ago

  • Business Wire

SINOVAC Board of Directors Prevails Against Advantech/Prime's New York Lawsuit

BEIJING--(BUSINESS WIRE)--SINOVAC Biotech Ltd. (NASDAQ: SVA) (' SINOVAC ' or the ' Company '), a leading provider of biopharmaceutical products in China, today announced it has prevailed against Advantech/Prime Success' ('Advantech/Prime') Petition for Emergency Injunctive Relief in the U.S. District Court for the Southern District of New York. The result in the New York court represents another failure in the campaign by Advantech/Prime in coordination with Vivo Capital (together known as the 'Dissenting Investor Group') to wrest control of SINOVAC from its recently installed, lawfully-elected Board of Directors (the 'current SINOVAC Board') in accordance with the Privy Council order and Antiguan Law, and to interfere with the payment of the US$55.00 per common share special cash dividend declared by the current SINOVAC Board. Following the New York court's ruling, the current SINOVAC Board is free to pursue its legal action in Antigua seeking to cancel the PIPE shares invalidly issued to the Dissenting Investor Group by the former illegitimate board (the 'Imposter Former Board'). If the current SINOVAC Board succeeds in legal proceedings on the PIPE shares, it has announced its intention to redistribute an additional US$11.00 per common share to SINOVAC's valid shareholders. Dr. Chiang Li, Chairman of the SINOVAC Board, commented, 'We will continue our mission to restore fairness and deliver value to all valid SINOVAC shareholders, starting with paying the $55.00 per share special cash dividend as soon as July 7, 2025.' The Dissenting Investor Group's self-serving, multi-pronged lawfare strategy against SINOVAC has one goal: to prevent all valid SINOVAC common shareholders from receiving any dividend payments unless the Dissenting Investor Group receives an allocation for their invalid PIPE shares, despite the fact that they have already received over US$1 billion in dividends from a SINOVAC operating subsidiary. The current SINOVAC Board has set aside in escrow the pro rata portion of dividends for the PIPE shares — funds the Dissenting Investor Group could receive if the legal proceedings they initiated rule in their favor. The current SINOVAC Board is fighting back – and winning. We feel certain that we will prevail against any further legal action by the Dissenting Investor Group and look forward to ensuring all valid shareholders receive their fair share. Your Vote is Important Your vote on or before July 8 will be about the future of SINOVAC, your receipt of your make-whole dividend payments in the near-term, and the long-term value of your investment. We urge you to keep SINOVAC's Board in place and vote on the WHITE proxy card ' AGAINST ' Proposal 1 to remove the current Board and ' AGAINST ' Proposal 2 to appoint the Reconstituted Imposter Board Slate. Your vote is critical to ensuring that SINOVAC remains on the path to stability, growth, and value creation for all shareholders. DISCARD any items you received asking you to vote for the Reconstituted Imposter Former Board Slate. If you have already voted for the Reconstituted Imposter Former Board Slate, you can subsequently revoke it by using the WHITE proxy card or WHITE voting instruction form to vote. Only your latest-dated vote will count! If you have questions about how your vote can be counted, please contact our proxy solicitor, Georgeson LLC, toll free at (844) 568-1506 in the U.S. and (646) 543-1968 outside the U.S. or via email at SinovacSpecialMeeting@ About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based biopharmaceutical company that focuses on the R&D, manufacturing, and commercialization of vaccines that protect against human infectious diseases. SINOVAC's product portfolio includes vaccines against COVID-19, enterovirus 71 (EV71) infected Hand-Foot-Mouth disease (HFMD), hepatitis A, varicella, influenza, poliomyelitis, pneumococcal disease, etc. The COVID-19 vaccine, CoronaVac®, has been approved for use in more than 60 countries and regions worldwide. The hepatitis A vaccine, Healive®, passed WHO prequalification requirements in 2017. The EV71 vaccine, Inlive®, is an innovative vaccine under "Category 1 Preventative Biological Products" and commercialized in China in 2016. In 2022, SINOVAC's Sabin-strain inactivated polio vaccine (sIPV) and varicella vaccine were prequalified by the WHO. SINOVAC was the first company to be granted approval for its H1N1 influenza vaccine Panflu.1®, which has supplied the Chinese government's vaccination campaign and stockpiling program. The Company is also the only supplier of the H5N1 pandemic influenza vaccine, Panflu®, to the Chinese government stockpiling program. SINOVAC continually dedicates itself to new vaccine R&D, with more combination vaccine products in its pipeline, and constantly explores global market opportunities. SINOVAC plans to conduct more extensive and in-depth trade and cooperation with additional countries, and business and industry organizations. Important Additional Information and Where to Find It In connection with SINOVAC's Special Meeting, SINOVAC has filed with the U.S. Securities and Exchange Commission ('SEC') and mailed to shareholders of record entitled to vote at the Special Meeting a definitive proxy statement and other documents, including a WHITE proxy card. SHAREHOLDERS ARE ENCOURAGED TO READ THE PROXY STATEMENT AND ALL OTHER RELEVANT DOCUMENTS WHEN FILED WITH THE SEC AND WHEN THEY BECOME AVAILABLE BECAUSE THOSE DOCUMENTS WILL CONTAIN IMPORTANT INFORMATION. Investors and other interested parties will be able to obtain the documents free of charge at the SEC's website, or from SINOVAC at its website: You may also obtain copies of SINOVAC's definitive proxy statement and other documents, free of charge, by contacting SINOVAC's Investor Relations Department at ir@ Safe Harbor Statement This announcement contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as 'may,' 'will,' 'expect,' 'anticipate,' 'aim,' 'estimate,' 'intend,' 'plan,' 'believe,' 'potential,' 'continue,' 'is/are likely to' or other similar expressions. Such statements are based upon current expectations and current market and operating conditions and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company's or Board's control, which may cause actual results, performance or achievements to differ materially from those in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in the Company's filings with the U.S. Securities and Exchange Commission. The Company and Board do not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.

Building a $28,000 TFSA Portfolio One Contribution at a Time
Building a $28,000 TFSA Portfolio One Contribution at a Time

Yahoo

time4 hours ago

  • Yahoo

Building a $28,000 TFSA Portfolio One Contribution at a Time

Written by Adam Othman at The Motley Fool Canada Ever since central banks in the US and Canada started cutting key interest rates, economic activity has picked up pace in both countries. While the rate cuts are currently paused amid trade and geopolitical tensions, analysts predict two more rate cuts of 25 basis points as inflation and tariff-related headwinds ease. Lower interest rates also mean you cannot generate too much interest income from cash held in high-interest savings accounts. If you have $28,000 of contribution room available in a Tax-Free Savings Account (TFSA), I can tell you a much better way of generating good monthly returns. The TSX has no shortage of monthly dividend-paying stocks. Building a portfolio of high-quality TSX stocks paying monthly distributions to shareholders can be a great way to generate extra monthly income. Here's a table giving you a quick look at how a hypothetical amount of around $28,000 across three such TSX stocks can deliver $144 in monthly dividends in a TFSA without incurring taxes. After that, you can read a bit about each. Ticker Recent Price Number of Shares Amount Invested Monthly Dividends Per Share Total Monthly Payout Per Stock PZA $14.91 625 $9,318.75 $0.0775 $48.44 SIA $18.52 503 $9,315.56 $0.078 $39.23 $25.37 368 $9,336.16 $0.1542 $56.75 Total Monthly Payout $144.42 Pizza Pizza Royalty Corp. (TSX:PZA) is a $497.3 million market-cap company that owns and franchises quick-service restaurants under several brands, boasting almost 800 restaurants from one coast to the other. The monthly dividend-paying stock generates revenue by collecting royalties from its franchisees based on how much they sell, making its cash flows less vulnerable to wage increases or commodity price fluctuations, which weigh on many businesses in the industry. The brands under the company's banner consistently keep adding value to end consumers by updating menus and using creative brand messaging. The company is also planning to continue to increase its locations. I believe this stock can be a good investment for earning relatively safe monthly dividends. Sienna Senior Living Inc. (TSX:SIA) is a $1.7 billion market-cap giant in the senior living space. It is among the largest owners of senior housing facilities in Ontario, servicing the aging population. Occupancy rates are getting higher and higher, and it generates revenue from several business segments catering to different markets within Canada. As long as the growth in the senior population continues, so will the demand for the services that SIA stock offers. The company ended the first quarter of fiscal 2025 with $445 million in liquidity, indicating that it has more than enough capital to fund monthly dividends and acquire more facilities under its banner. It can be another solid investment to consider for monthly dividends. SmartCentres REIT (TSX: is a Real Estate Investment Trust (REIT) that can help you earn monthly income like a lazy landlord. If you have the cash outlay for stock market investing, you have the ability to invest in the real estate sector, all without the hassle of being an actual landlord. has a portfolio of almost 200 properties in key locations across the country, with over 95% of its tenants having a regional or national presence. Most of its revenue comes from commercial tenants offering essential services, giving it solid cash-generating opportunities. Boasting an impressive 98.4% occupancy rate, it can be a solid investment. I feel that you should take any opportunity you can to make more money, and the TFSA gives you the perfect chance to do that. The tax-sheltered nature of the account means you can enjoy the returns from your investments in the account without incurring taxes. The table at the start paints a picture of what the monthly income might look like with a hypothetical $28,000 across three monthly dividend stocks. Add capital gains in the long term into the mix and your total returns over a few years can be much higher. The post Building a $28,000 TFSA Portfolio One Contribution at a Time appeared first on The Motley Fool Canada. More reading Made in Canada: 5 Homegrown Stocks Ready for the 'Buy Local' Revolution [PREMIUM PICKS] Market Volatility Toolkit Best Canadian Stocks to Buy in 2025 Beginner Investors: 4 Top Canadian Stocks to Buy for 2025 5 Years From Now, You'll Probably Wish You Grabbed These Stocks Subscribe to Motley Fool Canada on YouTube Fool contributor Adam Othman has no position in any of the stocks mentioned. The Motley Fool recommends SmartCentres Real Estate Investment Trust. The Motley Fool has a disclosure policy. 2025

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store